跳轉至內容
Merck
  • Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.

Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.

Innate immunity (2014-08-20)
S Pauliina Turunen, Outi Kummu, Chunguang Wang, Kirsi Harila, Riikka Mattila, Marjo Sahlman, Pirkko J Pussinen, Sohvi Hörkkö
摘要

Periodontal infections increase the risk of atherosclerotic vascular disease via partly unresolved mechanisms. Of the natural IgM Abs that recognize molecular mimicry on bacterial epitopes and modified lipid and protein structures, IgM directed against oxidized low-density lipoprotein (LDL) is associated with atheroprotective properties. Here, the effect of natural immune responses to malondialdehyde-modified LDL (MDA-LDL) in conferring protection against atherosclerosis, which was accelerated by the major periodontopathogen Porphyromonas gingivalis, was investigated. LDL receptor-deficient (LDLR(-/-)) mice were immunized with mouse MDA-LDL without adjuvant before topical application challenge with live P. gingivalis. Atherosclerosis was analyzed after a high-fat diet, and plasma IgG and IgM Ab levels were measured throughout the study, and the secretion of IL-5, IL-10 and IFN-γ in splenocytes stimulated with MDA-LDL was determined. LDLR(-/-) mice immunized with MDA-LDL had elevated IgM and IgG levels to MDA-LDL compared with saline-treated controls. MDA-LDL immunization diminished aortic lipid depositions after challenge with P. gingivalis compared with mice receiving only P. gingivalis challenge. Immunization of LDLR(-/-) mice with homologous MDA-LDL stimulated the production of IL-5, implicating general activation of B-1 cells. Immune responses to MDA-LDL protected from the P. gingivalis-accelerated atherosclerosis. Thus, the linkage between bacterial infectious burden and atherogenesis is suggested to be modulated via natural IgM directed against cross-reactive epitopes on bacteria and modified LDL.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
HEPES, ≥99.5% (titration)
Sigma-Aldrich
HEPES, BioPerformance Certified, ≥99.5% (titration), suitable for cell culture
Sigma-Aldrich
胆固醇, Sigma Grade, ≥99%
Sigma-Aldrich
苦基磺酸 溶液, 5 % (w/v) in H2O, BioReagent, suitable for determination of primary amines
Sigma-Aldrich
HEPES, BioUltra, for molecular biology, ≥99.5% (T)
Sigma-Aldrich
胆固醇, powder, BioReagent, suitable for cell culture, ≥99%
Sigma-Aldrich
HEPES缓冲溶液, 1 M in H2O
SAFC
HEPES
Sigma-Aldrich
胆固醇, from sheep wool, ≥92.5% (GC), powder
Sigma-Aldrich
4,4′-二氨基二苯甲烷, ≥97.0% (GC)
Sigma-Aldrich
1,1,3,3-四甲氧基丙烷, 99%
SAFC
HEPES
Sigma-Aldrich
HEPES, BioXtra, suitable for mouse embryo cell culture, ≥99.5% (titration)
Sigma-Aldrich
SyntheChol ® NS0 补充, 500 ×, synthetic cholesterol, animal component-free, aqueous solution, sterile-filtered, suitable for cell culture
Supelco
胆固醇 溶液, certified reference material, 10 mg/mL in chloroform
SAFC
胆固醇、植物的, SyntheChol®
Sigma-Aldrich
HEPES, BioXtra, pH 5.0-6.5 (1 M in H2O), ≥99.5% (titration)
Supelco
胆固醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
胆固醇, from lanolin, ≥99.0% (GC)
Sigma-Aldrich
HEPES, anhydrous, free-flowing, Redi-Dri, ≥99.5%
Supelco
HEPES, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
苦基磺酸 溶液, 1 M in H2O
Sigma-Aldrich
抗 小鼠 IgG(Fc 特异性)-碱性磷酸酶 山羊抗, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
抗 小鼠 IgM(μ-链特异性) 山羊抗, affinity isolated antibody, lyophilized powder
Sigma-Aldrich
胆固醇, tested according to Ph. Eur.
Supelco
4,4′-二氨基二苯甲烷, analytical standard
SAFC
胆固醇, from sheep wool, Controlled origin, meets USP/NF testing specifications
Sigma-Aldrich
Anti-Mouse IgM (μ-chain specific)–Alkaline Phosphatase antibody produced in goat, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
HEPES, Vetec, reagent grade, 99.5%
Sigma-Aldrich
Anti-Mouse IgG (γ-chain specific) antibody produced in goat, affinity isolated antibody, lyophilized powder